Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CP21R7 (CP21) is an effective and specific GSK3β inhibitor. It is used as an activator of stem cells prior to the induction of differentiation of stem cells to smooth muscle and endothelial cells. CP21R7 can be combined with BMP4 to commit human pluripotent stem cells to a mesodermal fate.
説明 | CP21R7 (CP21) is an effective and specific GSK3β inhibitor. It is used as an activator of stem cells prior to the induction of differentiation of stem cells to smooth muscle and endothelial cells. CP21R7 can be combined with BMP4 to commit human pluripotent stem cells to a mesodermal fate. |
ターゲット&IC50 | PKCα:1900 nM., GSK-3β:1.8 nM |
別名 | CP21 |
分子量 | 317.34 |
分子式 | C19H15N3O2 |
CAS No. | 125314-13-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 1 mg/mL (3.15 mM)
DMSO: 59 mg/mL (185.9 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CP21R7 125314-13-8 Chromatin/Epigenetic Cytoskeletal Signaling PI3K/Akt/mTOR signaling Stem Cells GSK-3 PKC CP 21 Glycogen synthase kinase 3 Inhibitor CP-21 Glycogen synthase kinase-3 CP-21R7 CP21 inhibit inhibitor